Highlights
- Market Cap
- $4.91M
- Enterprise Value
- -$2.30M
- EPS (TTM)
- -$2.38
- Total Revenue (TTM)
- $6.00K
- Gross Profit (TTM)
- $3.81K
- EBITDA (TTM)
- -$6.02M
- Year Range
- $1.50 - $6.25
- ROA (TTM)
- -76.77%
- ROE (TTM)
- -79.78%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Creative Medical Technology Holdings Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Creative Medical Technology Holdings Inc (CELZ) has returned 5.10% so far this year and -5.07% over the past 12 months. Over the last ten years, CELZ has returned -56.37% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Creative Medical Technology Holdings Inc
- 1D
- 6.19%
- 1M
- 13.81%
- YTD
- 5.10%
- 6M
- -38.14%
- 1Y
- -5.07%
- 3Y*
- -25.59%
- 5Y*
- -58.69%
- 10Y*
- -56.37%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Nov 6, 2015, CELZ's average daily return is +2.22%, while the average monthly return is +44.84%. At this rate, your investment would double in approximately 0.2 years.
Historically, 27% of months were positive and 73% were negative. The best month was Apr 2016 with a return of +4,445.5%, while the worst month was Nov 2017 at -77.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 10 months.
On a daily basis, CELZ closed higher 34% of trading days. The best single day was Apr 28, 2016 with a return of +4,445.5%, while the worst single day was May 18, 2016 at -80.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.06% | -10.40% | 13.81% | 5.10% | |||||||||
| 2025 | 35.50% | 58.79% | -56.34% | -4.61% | 5.31% | 21.56% | 4.91% | 14.39% | 4.72% | -4.80% | -15.14% | -27.14% | -15.15% |
| 2024 | -8.24% | -1.65% | 25.24% | -14.78% | -2.03% | -11.49% | -9.87% | 0.29% | -10.92% | 33.55% | -35.63% | -13.32% | -49.89% |
| 2023 | 40.38% | 6.54% | -12.28% | 29.68% | -12.08% | -18.70% | 18.88% | -13.98% | 3.80% | -10.77% | 1.37% | 3.60% | 20.97% |
| 2022 | -7.24% | -11.22% | 114.29% | -51.79% | -51.01% | -18.57% | -1.33% | -5.68% | -36.96% | -2.27% | -4.67% | -7.03% | -82.76% |
| 2021 | -10.07% | 88.00% | -29.47% | 32.73% | -18.18% | -2.78% | -22.00% | -0.37% | -44.85% | -3.33% | -40.69% | -48.60% | -84.10% |
Benchmark Metrics
Creative Medical Technology Holdings Inc has an annualized alpha of 28647.09%, beta of -1.08, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 09, 2015.
- This stock participated in 239.55% of S&P 500 Index downside but only -28.27% of its upside — more exposed to losses than it benefited from rallies.
- Beta of -1.08 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 28,647.09%
- Beta
- -1.08
- R²
- 0.00
- Upside Capture
- -28.27%
- Downside Capture
- 239.55%
Return for Risk
Risk / Return Rank
CELZ ranks 41 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Creative Medical Technology Holdings Inc (CELZ) and compare them to a chosen benchmark (S&P 500 Index).
| CELZ | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.05 | 0.90 | -0.95 |
Sortino ratioReturn per unit of downside risk | 0.67 | 1.39 | -0.71 |
Omega ratioGain probability vs. loss probability | 1.10 | 1.21 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | -0.14 | 1.40 | -1.53 |
Martin ratioReturn relative to average drawdown | -0.22 | 6.61 | -6.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore CELZ risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Creative Medical Technology Holdings Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Creative Medical Technology Holdings Inc was 100.00%, occurring on Feb 5, 2026. The portfolio has not yet recovered.
The current Creative Medical Technology Holdings Inc drawdown is 100.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Jun 14, 2016 | 2425 | Feb 5, 2026 | — | — | — |
| -80% | May 18, 2016 | 1 | May 18, 2016 | 13 | Jun 7, 2016 | 14 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Creative Medical Technology Holdings Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Creative Medical Technology Holdings Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CELZ relative to other companies in the Biotechnology industry. Currently, CELZ has a P/S ratio of 863.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CELZ in comparison with other companies in the Biotechnology industry. Currently, CELZ has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |